UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

JNCI : Journal of the National Cancer Institute, 2012-10, Vol.104 (19), p.1503-1513

2012

Link zum Volltext

Verfügbarkeit prüfen

Immunizing against Anogenital Cancer: HPV Vaccines

PLoS pathogens, 2016-05, Vol.12 (5), p.e1005587-e1005587

2016

Link zum Volltext

Verfügbarkeit prüfen

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

Journal of Virology, 2007-12, Vol.81 (24), p.13927-13931

2007

Link zum Volltext

Verfügbarkeit prüfen

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor

PloS one, 2023-06, Vol.18 (6), p.e0285221-e0285221

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

mBio, 2021-01, Vol.12 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunologic Control of Mus musculus Papillomavirus Type 1

PLoS pathogens, 2015-10, Vol.11 (10), p.e1005243-e1005243

2015

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

Journal of Virology, 2008-05, Vol.82 (9), p.4638-4646

2008

Link zum Volltext

Verfügbarkeit prüfen

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

PloS one, 2021-09, Vol.16 (9), p.e0256937-e0256937

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study

Breast cancer research : BCR, 2018-11, Vol.20 (1), p.134-10, Article 134

2018

Link zum Volltext

Verfügbarkeit prüfen

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Cancer Immunology, Immunotherapy, 2021-04, Vol.70 (4), p.1049-1062

2021

Link zum Volltext

Verfügbarkeit prüfen

Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth

Clinical cancer research, 2006-08, Vol.12 (16), p.4933-4939

2006

Link zum Volltext

Verfügbarkeit prüfen

Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice

mBio, 2022-02, Vol.13 (1), p.e0325221

2022

Link zum Volltext

Verfügbarkeit prüfen

Optimization of multimeric human papillomavirus L2 vaccines

PloS one, 2013-01, Vol.8 (1), p.e55538-e55538

2013

Link zum Volltext

Verfügbarkeit prüfen

Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches

Journal of Virology, 2010-02, Vol.84 (3), p.1214-1220

2010

Link zum Volltext

Verfügbarkeit prüfen

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Clinical cancer research, 2014-06, Vol.20 (12), p.3174-3186

2014

Link zum Volltext

Verfügbarkeit prüfen

Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2

Journal of Virology, 2007-11, Vol.81 (21), p.11585-11592

2007

Link zum Volltext

Verfügbarkeit prüfen

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

PloS one, 2012-06, Vol.7 (6), p.e39741-e39741

2012

Link zum Volltext

Verfügbarkeit prüfen

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

JNCI : Journal of the National Cancer Institute, 2009-06, Vol.101 (11), p.782-792

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types

PloS one, 2014-05, Vol.9 (5), p.e97232-e97232

2014

Link zum Volltext

Verfügbarkeit prüfen

Erratum for Peng et al., "Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice"

mBio, 2022-04, Vol.13 (2), p.e0029622-e0029622

2022

Link zum Volltext

Verfügbarkeit prüfen

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2

Proceedings of the National Academy of Sciences - PNAS, 2008-04, Vol.105 (15), p.5850-5855

2008

Link zum Volltext

Verfügbarkeit prüfen

α,β-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells

Journal of medicinal chemistry, 2011-01, Vol.54 (2), p.449-456

2011

Link zum Volltext

Verfügbarkeit prüfen

Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions

Journal of Virology, 2009-10, Vol.83 (20), p.10515-10526

2009

Link zum Volltext

Verfügbarkeit prüfen

Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes

Vaccine, 2014-06, Vol.32 (28), p.3540-3547

2014

Link zum Volltext

Verfügbarkeit prüfen

Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor

Clinical cancer research, 2008-11, Vol.14 (22), p.7340-7347

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(224)

Publikationsform

Artikel
(284)
Buchkapitel
(1)

Sprache

Englisch
(285)
Japanisch
(48)

Erscheinungsjahr

n.n

Thema

Science & Technology
(236)
Life Sciences & Biomedicine
(216)
Humans
(188)
Female
(110)
Animals
(101)
Mice
(73)
Human Papillomavirus
(61)
Biological And Medical Sciences
(57)
Virology
(51)
Pharmacology & Pharmacy
(48)
Oncology
(38)
Papillomavirus Infections - Prevention & Control
(37)
Medical Sciences
(36)
Immunology
(35)
Papillomavirus Vaccines - Immunology
(35)
Cervical Cancer
(33)
Vaccines
(33)
Capsid Proteins - Immunology
(31)
Microbiology
(31)
Male
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Medical Letter On Drugs And Therapeutics
(41)
Journal Of Virology
(27)
Plos One
(16)
Clinical Cancer Research
(11)
Vaccine
(11)
Cancer Research
(9)
Virology
(9)
Nature Genetics
(8)
Genetics In Medicine
(5)
Mbio
(5)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses

Immunizing against Anogenital Cancer: HPV Vaccines

A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2

Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor

Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody

Immunologic Control of Mus musculus Papillomavirus Type 1

Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific Antibodies

Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors

Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

Delivery of Telomerase Reverse Transcriptase Small Interfering RNA in Complex with Positively Charged Single-Walled Carbon Nanotubes Suppresses Tumor Growth

Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice

Optimization of multimeric human papillomavirus L2 vaccines

Papillomavirus Prophylactic Vaccines: Established Successes, New Approaches

Small-Molecule RA-9 Inhibits Proteasome-Associated DUBs and Ovarian Cancer In Vitro and In Vivo via Exacerbating Unfolded Protein Responses

Protection of Rabbits against Challenge with Rabbit Papillomaviruses by Immunization with the N Terminus of Human Papillomavirus Type 16 Minor Capsid Antigen L2

Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate

Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines

Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types

Erratum for Peng et al., "Development of a Spontaneous HPV16 E6/E7-Expressing Head and Neck Squamous Cell Carcinoma in HLA-A2 Transgenic Mice"

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2

α,β-Unsaturated Carbonyl System of Chalcone-Based Derivatives Is Responsible for Broad Inhibition of Proteasomal Activity and Preferential Killing of Human Papilloma Virus (HPV) Positive Cervical Cancer Cells

Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions

Low doses of flagellin-L2 multimer vaccines protect against challenge with diverse papillomavirus genotypes

Ubiquitin Proteasome System Stress Underlies Synergistic Killing of Ovarian Cancer Cells by Bortezomib and a Novel HDAC6 Inhibitor

Suchergebnisse filtern